Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab

Neuromyelitis optica (NMO) is a disabling autoimmune disease associated with an elevation of anti-aquaporin 4 (AQP4) autoantibodies. Here, we present a case with NMO who responded to monthly administration of the anti-IL-6 receptor antibody tocilizumab. The treatment rapidly reduced the elevated num...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Araki, Manabu, Aranami, Toshimasa, Matsuoka, Takako, Nakamura, Masakazu, Miyake, Sachiko, Yamamura, Takashi
Format: Artigo
Sprog:Inglês
Udgivet: Springer Japan 2012
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3713263/
https://ncbi.nlm.nih.gov/pubmed/22782533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-012-0715-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker